StockData
ALX Oncology Holdings Inc logo

ALX Oncology Holdings Inc (ALXO) stock

ALXONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.97−0.03 (-3.47%)

Close on Nov 18, 2026Market cap $134.14MP/E –Yield –

ALX Oncology total assets

Total assets on the balance sheet at the end of each period.

ALX Oncology's total assets was $160.82M at Jun 30, 2026. For fiscal 2025 it was $59.05M, down 60.0% from the year before. The highest annual figure on record is $436.05M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$59.05M-60.0%
FY2024Dec 31, 2024$147.78M-39.1%
FY2023Dec 31, 2023$242.55M-20.9%
FY2022Dec 31, 2022$306.49M-19.4%
FY2021Dec 31, 2021$380.18M-12.8%
FY2020Dec 31, 2020$436.05M+3984.4%
FY2019Dec 31, 2019$10.68M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$160.82M+68.7%
Q1 FY2026Mar 31, 2026$178.33M+47.5%
Q4 FY2025Dec 31, 2025$59.05M-60.0%
Q3 FY2025Sep 30, 2025$82.72M-55.5%
Q2 FY2025Jun 30, 2025$95.32M-55.6%
Q1 FY2025Mar 31, 2025$120.90M-43.1%
Q4 FY2024Dec 31, 2024$147.78M-39.1%
Q3 FY2024Sep 30, 2024$185.72M-15.6%
Q2 FY2024Jun 30, 2024$214.62M-12.7%
Q1 FY2024Mar 31, 2024$212.65M-23.5%
Q4 FY2023Dec 31, 2023$242.55M-20.9%
Q3 FY2023Sep 30, 2023$220.11M-30.7%
Q2 FY2023Jun 30, 2023$245.93M-28.9%
Q1 FY2023Mar 31, 2023$278.14M-23.5%
Q4 FY2022Dec 31, 2022$306.49M-19.4%
Q3 FY2022Sep 30, 2022$317.69M-20.5%
Q2 FY2022Jun 30, 2022$346.02M-17.9%
Q1 FY2022Mar 31, 2022$363.68M-16.0%
Q4 FY2021Dec 31, 2021$380.18M-12.8%
Q3 FY2021Sep 30, 2021$399.73M+52.3%
Q2 FY2021Jun 30, 2021$421.29M+308.6%
Q1 FY2021Mar 31, 2021$432.91M+3955.0%
Q4 FY2020Dec 31, 2020$436.05M–
Q3 FY2020Sep 30, 2020$262.45M–
Q2 FY2020Jun 30, 2020$103.11M–
Q4 FY2019Dec 31, 2019$10.68M–

More ALX Oncology figures

See a number that looks wrong?